- Home
- NVG vs CERT Comparison
NVG vs CERT Comparison
Compare NVG & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVG
- CERT
- Stock Information
- Founded
- NVG 1999
- CERT 2008
- Country
- NVG United States
- CERT United States
- Employees
- NVG N/A
- CERT N/A
- Industry
- NVG Investment Managers
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- NVG Finance
- CERT Technology
- Exchange
- NVG Nasdaq
- CERT Nasdaq
- Market Cap
- NVG 2.7B
- CERT 2.3B
- IPO Year
- NVG N/A
- CERT 2020
- Fundamental
- Price
- NVG $12.26
- CERT $9.91
- Analyst Decision
- NVG
- CERT Buy
- Analyst Count
- NVG 0
- CERT 6
- Target Price
- NVG N/A
- CERT $15.80
- AVG Volume (30 Days)
- NVG 568.8K
- CERT 1.2M
- Earning Date
- NVG 01-01-0001
- CERT 05-06-2025
- Dividend Yield
- NVG 4.65%
- CERT N/A
- EPS Growth
- NVG N/A
- CERT N/A
- EPS
- NVG N/A
- CERT N/A
- Revenue
- NVG N/A
- CERT $385,148,000.00
- Revenue This Year
- NVG N/A
- CERT $11.44
- Revenue Next Year
- NVG N/A
- CERT $8.90
- P/E Ratio
- NVG N/A
- CERT N/A
- Revenue Growth
- NVG N/A
- CERT 8.70
- 52 Week Low
- NVG $9.68
- CERT $9.41
- 52 Week High
- NVG $12.21
- CERT $19.18
- Technical
- Relative Strength Index (RSI)
- NVG 37.09
- CERT 26.70
- Support Level
- NVG $12.13
- CERT $10.21
- Resistance Level
- NVG $12.52
- CERT $11.12
- Average True Range (ATR)
- NVG 0.11
- CERT 0.49
- MACD
- NVG -0.03
- CERT -0.05
- Stochastic Oscillator
- NVG 22.03
- CERT 14.20
About NVG Nuveen AMT-Free Municipal Credit Income Fund
Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax and federal alternative minimum tax applicable to individuals and enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the investment adviser believes are underrated or undervalued or represent undervalued municipal market sectors.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.